← Back to Clinical Trials
Recruiting NCT07014124

NCT07014124 Smoking Cessation for Fathers of Sick Children

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07014124
Status Recruiting
Phase
Sponsor The University of Hong Kong
Condition Cigarette Smoking
Study Type INTERVENTIONAL
Enrollment 160 participants
Start Date 2025-03-18
Primary Completion 2026-03-01

Eligibility & Interventions

Sex Male only
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Nicotine Replacement Therapy (NRT) SamplingmHealth-based motivational counsellingBrief cessation advice and self-help material

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 160 participants in total. It began in 2025-03-18 with a primary completion date of 2026-03-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The project aims to develop and examine the feasibility, acceptability, and preliminary effectiveness of a proactive intervention model combined brief advice, nicotine replacement therapy sampling and mHealth-based individual counselling in increasing smoking abstinence for fathers of sick children.

Eligibility Criteria

Inclusion criteria for parents: * Parents (mainly fathers) aged ≥18 years and smoke at least one cigarette (including alternative tobacco products) daily in the past seven days * Living with a child aged \<18 years who attended the clinic or were admitted to the pediatric ward * Hong Kong residents able to read and communicate in Cantonese or Putonghua * Owned a smartphone and can use an instant messaging app (e.g., WhatsApp, Facebook) Inclusion criteria for children * Children aged \<18 years who attended the clinic or were admitted to the pediatric ward * Lives with at least one or more parents who smoke at least one cigarette (including alternative tobacco products) daily in the past seven days * Able to provide biochemical samples (e.g. saliva) for purpose of research Exclusion criteria for parents * Smokers having a history of psychiatric/psychological disease or currently on regular psychotropic medications * Smokers using smoking cessation medications or other smoking cessation services or projects Exclusion criteria for children * Children who already have serious health diseases (e.g.chronic disease, genetic disease) * Children who are participating in other clinical trials that may affect the results of this study * Children who live in certain environments, such as those living in highly contaminated areas or areas with other potential disease-causing factors

Contact & Investigator

Central Contact

Shengzhi Zhao, PhD

✉ lubabezz@connect.hku.hk

📞 +852 6561 4500

Frequently Asked Questions

Who can join the NCT07014124 clinical trial?

This trial is open to male participants only, aged 18 Years or older, studying Cigarette Smoking. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07014124 currently recruiting?

Yes, NCT07014124 is actively recruiting participants. Contact the research team at lubabezz@connect.hku.hk for enrollment information.

Where is the NCT07014124 trial being conducted?

This trial is being conducted at Hong Kong, Hong Kong.

Who is sponsoring the NCT07014124 clinical trial?

NCT07014124 is sponsored by The University of Hong Kong. The trial plans to enroll 160 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology